The Role of Tissue Factor In Signaling Pathways of Pathological Conditions and Angiogenesis
Tissue factor (TF) is an integral transmembrane protein associated with the extrinsic coagulation pathway. TF gene expression is regulated in response to inflammatory cytokines, bacterial lipopolysaccharides, and mechanical injuries. TF activity may be affected by phosphorylation of its cytoplasmic...
Uložené v:
| Vydané v: | Current molecular medicine Ročník 24; číslo 9; s. 1135 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Netherlands
01.01.2024
|
| Predmet: | |
| ISSN: | 1875-5666, 1875-5666 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Tissue factor (TF) is an integral transmembrane protein associated with the extrinsic coagulation pathway. TF gene expression is regulated in response to inflammatory cytokines, bacterial lipopolysaccharides, and mechanical injuries. TF activity may be affected by phosphorylation of its cytoplasmic domain and alternative splicing. TF acts as the primary initiator of physiological hemostasis, which prevents local bleeding at the injury site. However, aberrant expression of TF, accompanied by the severity of diseases and infections under various pathological conditions, triggers multiple signaling pathways that support thrombosis, angiogenesis, inflammation, and metastasis. Protease-activated receptors (PARs) are central in the downstream signaling pathways of TF. In this study, we have reviewed the TF signaling pathways in different pathological conditions, such as wound injury, asthma, cardiovascular diseases (CVDs), viral infections, cancer and pathological angiogenesis. Angiogenic activities of TF are critical in the repair of wound injuries and aggressive behavior of tumors, which are mainly performed by the actions of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1 (HIF1-α). Pro-inflammatory effects of TF have been reported in asthma, CVDs and viral infections, including COVID-19, which result in tissue hypertrophy, inflammation, and thrombosis. TF-FVII induces angiogenesis via clotting-dependent and -independent mechanisms. Clottingdependent angiogenesis is induced via the generation of thrombin and cross-linked fibrin network, which facilitate vessel infiltration and also act as a reservoir for endothelial cells (ECs) growth factors. Expression of TF in tumor cells and ECs triggers clotting-independent angiogenesis through induction of VEGF, urokinase-type plasminogen activator (uPAR), early growth response 1 (EGR1), IL8, and cysteine-rich angiogenic inducer 61 (Cyr61). |
|---|---|
| AbstractList | Tissue factor (TF) is an integral transmembrane protein associated with the extrinsic coagulation pathway. TF gene expression is regulated in response to inflammatory cytokines, bacterial lipopolysaccharides, and mechanical injuries. TF activity may be affected by phosphorylation of its cytoplasmic domain and alternative splicing. TF acts as the primary initiator of physiological hemostasis, which prevents local bleeding at the injury site. However, aberrant expression of TF, accompanied by the severity of diseases and infections under various pathological conditions, triggers multiple signaling pathways that support thrombosis, angiogenesis, inflammation, and metastasis. Protease-activated receptors (PARs) are central in the downstream signaling pathways of TF. In this study, we have reviewed the TF signaling pathways in different pathological conditions, such as wound injury, asthma, cardiovascular diseases (CVDs), viral infections, cancer and pathological angiogenesis. Angiogenic activities of TF are critical in the repair of wound injuries and aggressive behavior of tumors, which are mainly performed by the actions of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1 (HIF1-α). Pro-inflammatory effects of TF have been reported in asthma, CVDs and viral infections, including COVID-19, which result in tissue hypertrophy, inflammation, and thrombosis. TF-FVII induces angiogenesis via clotting-dependent and -independent mechanisms. Clottingdependent angiogenesis is induced via the generation of thrombin and cross-linked fibrin network, which facilitate vessel infiltration and also act as a reservoir for endothelial cells (ECs) growth factors. Expression of TF in tumor cells and ECs triggers clotting-independent angiogenesis through induction of VEGF, urokinase-type plasminogen activator (uPAR), early growth response 1 (EGR1), IL8, and cysteine-rich angiogenic inducer 61 (Cyr61).Tissue factor (TF) is an integral transmembrane protein associated with the extrinsic coagulation pathway. TF gene expression is regulated in response to inflammatory cytokines, bacterial lipopolysaccharides, and mechanical injuries. TF activity may be affected by phosphorylation of its cytoplasmic domain and alternative splicing. TF acts as the primary initiator of physiological hemostasis, which prevents local bleeding at the injury site. However, aberrant expression of TF, accompanied by the severity of diseases and infections under various pathological conditions, triggers multiple signaling pathways that support thrombosis, angiogenesis, inflammation, and metastasis. Protease-activated receptors (PARs) are central in the downstream signaling pathways of TF. In this study, we have reviewed the TF signaling pathways in different pathological conditions, such as wound injury, asthma, cardiovascular diseases (CVDs), viral infections, cancer and pathological angiogenesis. Angiogenic activities of TF are critical in the repair of wound injuries and aggressive behavior of tumors, which are mainly performed by the actions of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1 (HIF1-α). Pro-inflammatory effects of TF have been reported in asthma, CVDs and viral infections, including COVID-19, which result in tissue hypertrophy, inflammation, and thrombosis. TF-FVII induces angiogenesis via clotting-dependent and -independent mechanisms. Clottingdependent angiogenesis is induced via the generation of thrombin and cross-linked fibrin network, which facilitate vessel infiltration and also act as a reservoir for endothelial cells (ECs) growth factors. Expression of TF in tumor cells and ECs triggers clotting-independent angiogenesis through induction of VEGF, urokinase-type plasminogen activator (uPAR), early growth response 1 (EGR1), IL8, and cysteine-rich angiogenic inducer 61 (Cyr61). Tissue factor (TF) is an integral transmembrane protein associated with the extrinsic coagulation pathway. TF gene expression is regulated in response to inflammatory cytokines, bacterial lipopolysaccharides, and mechanical injuries. TF activity may be affected by phosphorylation of its cytoplasmic domain and alternative splicing. TF acts as the primary initiator of physiological hemostasis, which prevents local bleeding at the injury site. However, aberrant expression of TF, accompanied by the severity of diseases and infections under various pathological conditions, triggers multiple signaling pathways that support thrombosis, angiogenesis, inflammation, and metastasis. Protease-activated receptors (PARs) are central in the downstream signaling pathways of TF. In this study, we have reviewed the TF signaling pathways in different pathological conditions, such as wound injury, asthma, cardiovascular diseases (CVDs), viral infections, cancer and pathological angiogenesis. Angiogenic activities of TF are critical in the repair of wound injuries and aggressive behavior of tumors, which are mainly performed by the actions of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1 (HIF1-α). Pro-inflammatory effects of TF have been reported in asthma, CVDs and viral infections, including COVID-19, which result in tissue hypertrophy, inflammation, and thrombosis. TF-FVII induces angiogenesis via clotting-dependent and -independent mechanisms. Clottingdependent angiogenesis is induced via the generation of thrombin and cross-linked fibrin network, which facilitate vessel infiltration and also act as a reservoir for endothelial cells (ECs) growth factors. Expression of TF in tumor cells and ECs triggers clotting-independent angiogenesis through induction of VEGF, urokinase-type plasminogen activator (uPAR), early growth response 1 (EGR1), IL8, and cysteine-rich angiogenic inducer 61 (Cyr61). |
| Author | Heidari, Zahra Razban, Vahid Naeimzadeh, Yasaman Khajeh, Sahar Fallahi, Jafar Savardashtaki, Amir |
| Author_xml | – sequence: 1 givenname: Zahra orcidid: 0000-0003-3918-7573 surname: Heidari fullname: Heidari, Zahra organization: Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran – sequence: 2 givenname: Yasaman orcidid: 0000-0003-3937-1426 surname: Naeimzadeh fullname: Naeimzadeh, Yasaman organization: Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran – sequence: 3 givenname: Jafar surname: Fallahi fullname: Fallahi, Jafar organization: Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran – sequence: 4 givenname: Amir orcidid: 0000-0003-1700-9426 surname: Savardashtaki fullname: Savardashtaki, Amir organization: Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran – sequence: 5 givenname: Vahid orcidid: 0000-0002-8966-6081 surname: Razban fullname: Razban, Vahid organization: Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran – sequence: 6 givenname: Sahar orcidid: 0000-0003-1614-2962 surname: Khajeh fullname: Khajeh, Sahar organization: Bone and Joint Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37817529$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE1Lw0AYhBepaK3-BdmDBy_R7PfmWIrVQkHRevIQNpt304V0t2YTpP_eFBU8zcA8DMxcoEmIARC6IfkdJYrf54QIKQXlORVacUlZXpCCSFEwcYKmRCuRjYCc_PNn6JwpTZSgxRR9bLaAX2MLODq88SkNgJfG9rHDq4DffBNM60ODX0y__TKHdMSOPrax8da0eBFD7XsfQ8Im1HgeGh8bCJB8ukSnzrQJrn51ht6XD5vFU7Z-flwt5uus4kr1ma2c0ERwxaRwStZSCwmOaVFpZqHW3FKXjyEDZimz2lXcMGoVUGqOS-kM3f707rv4OUDqy51PFtrWBIhDKum4XAumiRzR6190qHZQl_vO70x3KP8Ood8izGNx |
| CitedBy_id | crossref_primary_10_1016_j_pharma_2024_08_005 crossref_primary_10_1002_ila2_70003 crossref_primary_10_1186_s12871_024_02827_9 crossref_primary_10_1177_09673911251320463 crossref_primary_10_1093_procel_pwaf002 crossref_primary_10_1002_cbf_70021 crossref_primary_10_1007_s00109_023_02409_1 crossref_primary_10_1016_j_cca_2025_120549 crossref_primary_10_3389_fimmu_2025_1593885 crossref_primary_10_1371_journal_pone_0311143 |
| ContentType | Journal Article |
| Copyright | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| Copyright_xml | – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.2174/0115665240258746230919165935 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 1875-5666 |
| ExternalDocumentID | 37817529 |
| Genre | Journal Article Review |
| GroupedDBID | CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-b477t-cbf581547365f76d6856ef385b83ced84c2f07363e3c23c8fb4a32c7e22a16592 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 14 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001263323000008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1875-5666 |
| IngestDate | Fri Jul 11 06:54:25 EDT 2025 Mon Jul 21 05:40:52 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | viral infection angiogenesis Tissue factor asthma cancer cardiovascular diseases pathological conditions |
| Language | English |
| License | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b477t-cbf581547365f76d6856ef385b83ced84c2f07363e3c23c8fb4a32c7e22a16592 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-8966-6081 0000-0003-3918-7573 0000-0003-1614-2962 0000-0003-1700-9426 0000-0003-3937-1426 |
| PMID | 37817529 |
| PQID | 2875853816 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2875853816 pubmed_primary_37817529 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-01-01 |
| PublicationDateYYYYMMDD | 2024-01-01 |
| PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Current molecular medicine |
| PublicationTitleAlternate | Curr Mol Med |
| PublicationYear | 2024 |
| Score | 2.4690483 |
| SecondaryResourceType | review_article |
| Snippet | Tissue factor (TF) is an integral transmembrane protein associated with the extrinsic coagulation pathway. TF gene expression is regulated in response to... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1135 |
| SubjectTerms | Angiogenesis - metabolism Angiogenesis - pathology Animals Asthma - metabolism Asthma - pathology Cardiovascular Diseases - metabolism Cardiovascular Diseases - pathology COVID-19 - metabolism COVID-19 - pathology COVID-19 - virology Humans Inflammation - metabolism Inflammation - pathology Neoplasms - metabolism Neoplasms - pathology SARS-CoV-2 - metabolism Signal Transduction Thromboplastin - genetics Thromboplastin - metabolism |
| Title | The Role of Tissue Factor In Signaling Pathways of Pathological Conditions and Angiogenesis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37817529 https://www.proquest.com/docview/2875853816 |
| Volume | 24 |
| WOSCitedRecordID | wos001263323000008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1LS8QwEMeDuiJefOBrfRFhr0WbNI-eZFlc9OCy6AoLHkqaJmVB2tWuit_embaLFw-Cl1JKCmUymfkxk_RPSM8CA5hU2UBg4zASngfaXJlAcJhwoXkoTVqLTajRSE-n8bgtuFXttsplTKwDdVZarJFfAtkD2WKb63r-GqBqFHZXWwmNVdLhgDLo1Wpan36D0QGQitwgPdztDNyNkqfwRGA7QWgVQd6HXAl0JOJW6-1XvqzzzHD7v1-4Q7ZawqT9xiV2yYor9sgzuAN9KF8cLT2d1Mamw1pqh94V9HGWI48XOR0DEH6arwqH4f0yNNJBib1t9FFqioz2i3xW5hgnZ9U-eRreTAa3QaurEKSRUovApl7oEEWHpfBKZlIL6TzXItXcukxHlnlY-ZI7bhm32qeR4cwqx5hBc7EDslaUhTsiNPOW2dRlFmY5yrjTNmZpqG1ouJGRueqSi6WtEvBbbEaYwpXvVfJjrS45bAyezJsfbCRcaaAaFh__4e0TssmAM5qqyCnpeFi17oys24_FrHo7rx0CrqPx_TfO3b-f |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+Tissue+Factor+In+Signaling+Pathways+of+Pathological+Conditions+and+Angiogenesis&rft.jtitle=Current+molecular+medicine&rft.au=Heidari%2C+Zahra&rft.au=Naeimzadeh%2C+Yasaman&rft.au=Fallahi%2C+Jafar&rft.au=Savardashtaki%2C+Amir&rft.date=2024-01-01&rft.issn=1875-5666&rft.eissn=1875-5666&rft.volume=24&rft.issue=9&rft.spage=1135&rft_id=info:doi/10.2174%2F0115665240258746230919165935&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1875-5666&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1875-5666&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1875-5666&client=summon |